TrialProstate cancer and prostatic diseases2020

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT.

Mahbubl Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.